Do Over: The PRAECIS Trial, Predicting Severe Preeclampsia

We rarely get feedback on episodes of Freely Filtered. That is until we screw up. And our episode on the PRAECIS trial did not go smoothly. One of our experts got called into the hospital and then when she came back for a one-on-one with Joel Topf, it turns out she had no experience with the test. Our bad.

So, we went back and rerecorded a podcast. Join us as we reexamine the newly FDA-approved blood test looking at the ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PIGF) for the diagnosis of severe preeclampsia. The PRAECIS trial.